Quantcast

Latest Blastoma Stories

2014-06-12 12:27:16

LONDON, June 12, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014 http://www.reportbuyer.com/pharma_healthcare/research_r_d/clinical_trials/wilms_tumor_nephroblastoma_global_clinical_trials_review.html Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1, 2014 Summary GlobalData's clinical trial report, "Wilms' Tumor (Nephroblastoma) Global Clinical Trials Review, H1,...

2014-06-09 23:09:24

In CHAMPS Oncology's most recent blog post, Cancer Registry on the TODAY Show, Rhonda Spoden shares her thoughts on the topic. Cleveland, OH (PRWEB) June 09, 2014 In CHAMPS Oncology's most recent blog post, Cancer Registry on the TODAY Show, Rhonda Spoden shares her thoughts on the topic. It isn’t often the cancer registry makes national headlines, and (as much as she loves and respects the profession) Spoden never expected to hear about the cancer registry on the TODAY Show....

2014-06-02 16:25:16

Cancers characterized by DICER1 genetic defect are advancing new approach to cancer treatments, cures MINNEAPOLIS, June 2, 2014 /PRNewswire/ -- Recent findings by researchers from the International Pleuropulmonary Blastoma (PPB) Registry and International Ovarian and Testicular Stromal (OTST) Tumor Registry, both based at Children's Hospitals and Clinics of Minnesota, have advanced the potential for early diagnosis and proactive treatment of children in families affected by...

2014-03-27 12:30:55

A St. Jude Children's Research Hospital-led study identified two adult cancer drugs with potential to improve treatment of a high-risk childhood brain tumor; the drugs are now part of a pediatric clinical trial MEMPHIS, Tenn., March 27, 2014 /PRNewswire-USNewswire/ -- The quest to improve survival of children with a high-risk brain tumor has led St. Jude Children's Research Hospital investigators to two drugs already used to treat adults with breast, pancreatic, lung and other...

2013-05-09 23:04:11

A particular tumor suppressor gene that fights cancer cells does more than clamp down on unabated cell division -- the hallmark of the disease -- it also can help make cells more fit by allowing them to fend off stress, says a University of Colorado Boulder study. Boulder, CO (PRWEB) May 09, 2013 A particular tumor suppressor gene that fights cancer cells does more than clamp down on unabated cell division -- the hallmark of the disease -- it also can help make cells more fit by allowing...

2013-04-05 23:00:13

Voices Against Brain Cancer (VABC) responds to an article posted by Bioscience Technology detailing how the blockage of molecular pathways in the brain may be a contributing factor to the development of brain tumors. Bohemia, NY (PRWEB) April 05, 2013 On April 5, 2013, Voices Against Brain Cancer (VABC) responds to an article posted by Bioscience Technology detailing how the blockage of molecular pathways in the brain could be a contributing factor in the development of brain tumors. The...

2013-03-13 14:48:34

A team of Canadian and international cancer researchers led by Dr. Brenda Gallie at the Princess Margaret Cancer Centre, University Health Network (UHN), has discovered a new type of retinoblastoma, a rapidly developing eye cancer that affects very young babies— a finding that can immediately change clinical practice and optimize care for these children. The finding, published online today in Lancet Oncology, is a breakthrough in recognizing that a single cancer gene (an oncogene)...

2012-12-13 12:26:27

Researchers at Michigan State University have discovered a protein that does its best work with one foot in the grave. The study, which appears in the current issue of the Journal of Biological Chemistry, focuses on the nontraditional lifestyle of Retinoblastoma tumor suppressor proteins, which could lead to new ways to treat cancer. “Retinoblastoma proteins are unique in that they use controlled destruction to do their jobs in a timely but restrained fashion,” said Liang...

Origin Matters For Brain Tumors
2012-11-14 10:22:14

Sanford-Burnham Medical Research Institute Brain tumors arising from different cell types might require different–and more personalized–treatment approaches. Cancers arise when a normal cell acquires a mutation in a gene that regulates cellular growth or survival. But the particular cell this mutation happens in–the cell of origin–can have an enormous impact on the behavior of the tumor, and on the strategies used to treat it. Robert Wechsler-Reya, Ph.D.,...

2012-10-15 15:23:34

After leukaemia and brain tumors, neuroblastoma is the most common form of cancer to affect children. A thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden, has studied a DNA method which is now used for all cases of neuroblastoma in Sweden, and which has led to more effective treatment at individual level. Neuroblastoma affects around 20 children each year, most of them under the age of two. This form of cancer, which affects the peripheral nervous system, is...


Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.